This phase 1 study is to assess safety, tolerability and pharmacokinetics of three different formulations of XP19986 in healthy adult volunteers.
Phase of Trial: Phase I
Latest Information Update: 22 Nov 2005
At a glance
- Drugs Arbaclofen placarbil (Primary)
- Indications Gastro-oesophageal reflux; Muscle spasticity
- Focus Adverse reactions; Pharmacokinetics
- 22 Nov 2005 New trial record.